Breast Cancer Drug for Drug-resistant Thyroid Cancer

Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer. It is mostly treated with the drug vemurafenib. But most PTC patients develop resistance and progress. However, a research by a Harvard Medical School team found that papillary thyroid carcinoma can be treated effectively with a combination of drugs.

Related Links